Saturday 7 November 2026 Export ZVRA’s income statement to Excel — free account

Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $106.5 million, up 350.9% from fiscal 2024.

Revenue: +44.9%
EPS: +3,333.0%
Free cash flow: +106.8%
Total debt: +4.07%

Quarter to September 2026, against a year earlier

11.55 1.02 +9.69%

Follow ZVRA

Alert me

Market cap: $626.6M
P/E: 9.0×
Fwd P/E: 9.2×
Dividend yield: —
F-score: 6/9
Altman Z: 0.63
Beneish M: 1.46
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	7	6	6
ROE Full definition →		78.32%	93.60%	33.44%	40.29%
ROA Full definition →		32.88%	51.19%	20.03%	25.69%
ROIC Full definition →		(153.83%)	(65.48%)	0.00%	129.48%
Return on Tangible Assets Full definition →		41.31%	62.99%	27.54%	40.46%
Average Days of Receivables Full definition →		79.73	65.96	60.33	49.26
Free Cash Flow per Share Full definition →		(0.04)	0.21	1.39	1.47
Free Cash Flow Full definition →		(1.98)	12.49	82.01	87.07
Capital Expenditures Full definition →		(0.39)	(0.28)	48.61	48.34
Other line items
Cash ROIC Full definition →		(0.49%)	3.07%	18.67%	20.04%
Accounts Receivable Turnover Full definition →		6.31	7.05	6.68	8.03
Accounts Payable Turnover Full definition →		0.89	1.15	0.41	0.54
Inventory Turnover Full definition →		8.89	7.00	3.47	3.04
Average Days of Payables Full definition →		256.84	250.45	824.62	740.84
Days of Inventory on Hand Full definition →		38.53	49.50	144.64	166.35
Tax Rate Full definition →		(0.04)	(0.07)	(0.16)	(0.13)
Research and Development Expense of Revenue Full definition →		11.97%	11.35%	10.97%	11.12%
Selling, General and Administrative Expense of Revenue Full definition →		72.90%	64.48%	54.85%	51.99%
Share Based Compensation of Revenue Full definition →		11.94%	10.32%	9.65%	8.82%
Interest Coverage Full definition →		(7.89)	(0.70)	14.43	24.55
Operating CF/Net income Full definition →		(0.02)	0.11	0.60	0.52
Depreciation/Fixed assets Full definition →		121.96	134.97	(2.81)	(0.72)
Capex/Depreciation Full definition →		(0.01)	0.00	(26.99)	(82.34)
Revenue per Share Full definition →		1.92	2.09	2.30	2.49
Operating CF per Share Full definition →		(0.03)	0.22	0.56	0.65
Capex per Share Full definition →		(0.01)	0.00	0.82	0.81
Capex to Sales Full definition →		0.00	0.00	(0.36)	(0.33)

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly